Healthcare >> Sector Roundtables >> January 20, 2003

Roundtable Forum: Medical Devices & Supplies

ROBERT M. GOLDMAN is a Senior Vice President and Analyst at Buckingham Research Group, Inc., covering health care (medical devices and supplies). He has 14 years' experience in the securities industry, 10 covering the medical devices and supplies industry. He was named to Institutional Investor and The Wall Street Journal All-Star teams while at Salomon Smith Barney and Dean Witter Reynolds. He served as Director of Research for the Americas and head of US Equities for Paribas and Credit Lyonnais. His industry experience prior to entering the financial sector was with Baxter International, Shell Chemical and General Electric. He received a BS in Chemical Engineering from Rensselaer Polytechnic Institute and an MBA from Harvard Business School. Profile
MARK LANDY is a Vice President and Senior Research Analyst at Leerink Swann & Company. Prior to joining the firm he was associated with Investor AB, Merlin BioMed Group, and New Era Capital. Mr. Landy earned a DDS from the University of the Witwatersrand, South Africa, and a BBA from The Wharton School, University of Pennsylvania. Mr. Landy is a member of the South African Medical and Dental Council, the South African Society of Surgeons, the British Medical Council and the British Dental Association. JAN WALD joined A.G. Edwards in June 2000 and focuses his research efforts in the medical technology industry. Dr. Wald is an active publisher of industry and company-specific research reports focused in the areas of cardiology and neurology. He has previous work experience in the medical technology industry, working at Guidant Corp. and Honeywell, Inc. At Guidant, Dr. Wald managed clinical programs as well as the development of the algorithms and software for two implantable defibrillators. At Honeywell he managed image processing algorithm and robotics programs. Prior to joining A.G. Edwards, Dr. Wald was a Senior Vice President and Senior Analyst in medical technology at George K. Baum & Co. He has a PhD from Brandeis University and an MBA from University of St. Thomas. Dr. Wald also holds a patent on atrial fibrillation detection. Profile
FREDERICK A. WISE, CFA, is a Managing Director at Bear, Stearns & Co., covering the medical supplies and devices industry. Mr. Wise is a six-year member of the Institutional Investor All America Research Team. In 1999 he was ranked number two and in 2000 he was ranked number three. He was named to the 2000 Wall Street Journal All-Star Analysts Survey for earnings forecasting. He was also ranked number four by The Reuters Survey 2000. Mr. Wise has a unique valuation approach, and has accurately anticipated the underperformance of stocks, as well as the performance of the industry in recent years. Prior to joining Bear Stearns, he was an Analyst at Kidder Peabody & Co. and Forbes, Inc. Mr. Wise received an MA and a BA from the Manhattan School of Music. Profile
DOUGLAS EAYRS primarily covers medical technology companies and selected biotechnology and diagnostics companies at Dougherty & Company LLC. He has over 10 years of experience as an investment analyst covering medical technology and selected biotech companies. He also worked over three years in the biotech industry as a Vice President of Finance and assisted in the completion of several financings to fund company-sponsored late- stage clinical trials. Mr. Eayrs is a Chartered Financial Analyst, has a Master of Arts degree in Economics from Marquette University and a Bachelor of Arts degree from the University of Minnesota. In 1996, he was named an All-star Analyst in the medical products group in The Wall Street Journal's annual survey. Profile
TWST: Doug, could you start us off with a description of what

you're currently focusing on in the medical supplies and devices


Mr. Eayrs: I primarily use a very focused micro approach. I